Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Photolithography Microstructure Myopia Management Lenses in Preventing and Controlling Myopia in Children and Adolescents

NCT: NCT07514039 · ENROLLING_BY_INVITATION

NCT IDNCT07514039
StatusENROLLING_BY_INVITATION
Start Date2026-02-01
Completion2027-12-31

Brief Summary

Evaluate the effectiveness of different lithographic microstructured myopia management lenses in controlling the progression of myopia in children and adolescents, as well as the safety and comfort of wearing them. Explore effective defocus microlens designs for myopia control and the feasibility of applying lithographic microstructured myopia management lenses in myopia prevention and control.

Frequently Asked Questions

What is Photolithography Microstructure Myopia Management Lenses in Preventing and Controlling Myopia in Children and Adolescents?

Photolithography Microstructure Myopia Management Lenses in Preventing and Controlling Myopia in Children and Adolescents is a clinical trial registered under NCT07514039. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT07514039?

The current status of NCT07514039 (Photolithography Microstructure Myopia Management Lenses in Preventing and Controlling Myopia in Children and Adolescents) is: ENROLLING_BY_INVITATION.

When did Photolithography Microstructure Myopia Management Lenses in Preventing and Controlling Myopia in Children and Adolescents start?

Photolithography Microstructure Myopia Management Lenses in Preventing and Controlling Myopia in Children and Adolescents started on 2026-02-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑